per cent, while Ratiopharm is Europe’s largest and fifth overall with 3 per cent.Aside from acquiring Wyeth, Pfizer has nearly gone ex-growth and will soon lose exclusivity on blockbusters Lipitor and Effexor. Although shrinking research spending, it...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer / Ratiopharm
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account